A collaboration between Agilent Technologies and Double Helix Technologies (Doulix) has been announced for the promotion of the SureVector Cloning system.
Collaboration
Through this partnership, cloning kits will be available through Doulix’s web platform where customers will be able to choose among SureVector’s standard DNA parts to design custom plasmids. SureVector works by allowing the combination of standard validated parts in synthetic biology to create novel vector constructs. It can assemble custom plasmids for mammalian, E. coli and yeast cells by combining Agilent’s functional DNA modules with custom genes and components.
Doulix is a toolkit for synthetic biology that allows users to design, validate and synthesize custom DNA vectors. It combines the convenience of pre-made standard DNA parts with a full-fledge sequence editor, and also offers a validation algorithm that allows users to review their constructs for common design flaws before proceeding to synthesis.
“Today, the unmatched flexibility of SureVector and the design capability of Doulix come together to unlock the full potential of synthetic biology,” said Davide De Lucrezia, managing director of Doulix.
“This collaboration is an exciting step forward for SureVector,” stated Laura Whitman, Global Synthetic Biology product manager for Agilent. “It allows researchers to create individual vectors and the ability to customise any fragment in the SureVector system.”